Alpha Centric Advisors LLC Biogen Inc. Transaction History

Alpha Centric Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 25, 2022	SELL	$223.92 - $287.77 $89,568 - $115,108	-400 Closed	0 $0
Q4 2020 Mar 11, 2022	BUY	$236.26 - $355.63 $87,416 - $131,583	370 Added 1233.33%	400 $98,000
Q3 2020 Mar 11, 2022	SELL	$264.77 - $305.71 $23,829 - $27,513	-90 Reduced 75.0%	30 $9,000
Q2 2020 Mar 11, 2022	BUY	$258.66 - $342.55 $31,039 - $41,106	120 New	120 $32,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.